Logo image of AMRZ

AMRIZE LTD (AMRZ) Stock Fundamental Analysis

NYSE:AMRZ - CH1430134226 - Common Stock

51.24 USD
+1.8 (+3.64%)
Last: 8/22/2025, 8:04:00 PM
51.24 USD
0 (0%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, AMRZ scores 2 out of 10 in our fundamental rating. AMRZ was compared to 13 industry peers in the Construction Materials industry. Both the profitability and financial health of AMRZ have multiple concerns. AMRZ has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AMRZ had positive earnings in the past year.
AMRZ Yearly Net Income VS EBIT VS OCF VS FCFAMRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.36%, AMRZ is doing worse than 69.23% of the companies in the same industry.
AMRZ's Return On Equity of 10.25% is on the low side compared to the rest of the industry. AMRZ is outperformed by 84.62% of its industry peers.
AMRZ's Return On Invested Capital of 7.38% is in line compared to the rest of the industry. AMRZ outperforms 53.85% of its industry peers.
Industry RankSector Rank
ROA 5.36%
ROE 10.25%
ROIC 7.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMRZ Yearly ROA, ROE, ROICAMRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 10.89%, AMRZ is in line with its industry, outperforming 46.15% of the companies in the same industry.
The Operating Margin of AMRZ (18.16%) is better than 61.54% of its industry peers.
With a Gross Margin value of 26.23%, AMRZ is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRZ Yearly Profit, Operating, Gross MarginsAMRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

AMRZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AMRZ has about the same amount of shares outstanding.
The debt/assets ratio for AMRZ has been reduced compared to a year ago.
AMRZ Yearly Shares OutstandingAMRZ Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M 500M
AMRZ Yearly Total Debt VS Total AssetsAMRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.35 indicates that AMRZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.35, AMRZ is doing worse than 61.54% of the companies in the same industry.
A Debt/Equity ratio of 0.52 indicates that AMRZ is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.52, AMRZ perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACC0.78
WACC9.42%
AMRZ Yearly LT Debt VS Equity VS FCFAMRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.38 indicates that AMRZ should not have too much problems paying its short term obligations.
AMRZ's Current ratio of 1.38 is on the low side compared to the rest of the industry. AMRZ is outperformed by 69.23% of its industry peers.
A Quick Ratio of 0.85 indicates that AMRZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.85, AMRZ is doing worse than 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.85
AMRZ Yearly Current Assets VS Current LiabilitesAMRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.26% over the past year.
The Revenue has been growing slightly by 0.23% in the past year.
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.5%
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.71%

3.2 Future

Based on estimates for the next years, AMRZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.03% on average per year.
AMRZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.44% yearly.
EPS Next Y21.74%
EPS Next 2Y17.39%
EPS Next 3Y16.03%
EPS Next 5YN/A
Revenue Next Year4.31%
Revenue Next 2Y5.01%
Revenue Next 3Y5.44%
Revenue Next 5YN/A

3.3 Evolution

AMRZ Yearly Revenue VS EstimatesAMRZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
AMRZ Yearly EPS VS EstimatesAMRZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.28, AMRZ is valued on the expensive side.
Based on the Price/Earnings ratio, AMRZ is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.24, AMRZ is valued at the same level.
A Price/Forward Earnings ratio of 16.13 indicates a correct valuation of AMRZ.
Based on the Price/Forward Earnings ratio, AMRZ is valued a bit cheaper than 76.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, AMRZ is valued rather cheaply.
Industry RankSector Rank
PE 22.28
Fwd PE 16.13
AMRZ Price Earnings VS Forward Price EarningsAMRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRZ indicates a somewhat cheap valuation: AMRZ is cheaper than 76.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.07
AMRZ Per share dataAMRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AMRZ's earnings are expected to grow with 16.03% in the coming years.
PEG (NY)1.02
PEG (5Y)N/A
EPS Next 2Y17.39%
EPS Next 3Y16.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMRZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMRIZE LTD

NYSE:AMRZ (8/22/2025, 8:04:00 PM)

After market: 51.24 0 (0%)

51.24

+1.8 (+3.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-34644.9%
Market Cap28.34B
Analysts80
Price TargetN/A
Short Float %0.61%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.28
Fwd PE 16.13
P/S 2.42
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB 17.62
EV/EBITDA 11.07
EPS(TTM)2.3
EY4.49%
EPS(NY)3.18
Fwd EY6.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.16
BVpS22.48
TBVpS2.91
PEG (NY)1.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.36%
ROE 10.25%
ROCE 10.3%
ROIC 7.38%
ROICexc 7.59%
ROICexgc 15.69%
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.15
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.85
Altman-Z 2.35
F-ScoreN/A
WACC9.42%
ROIC/WACC0.78
Cap/Depr(3y)69.39%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)137.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.5%
EPS Next Y21.74%
EPS Next 2Y17.39%
EPS Next 3Y16.03%
EPS Next 5YN/A
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.71%
Revenue Next Year4.31%
Revenue Next 2Y5.01%
Revenue Next 3Y5.44%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.08%
OCF growth 3YN/A
OCF growth 5YN/A